New blood pressure drug shows promise in japanese study
NCT ID NCT06423352
First seen Apr 30, 2026 · Last updated May 07, 2026 · Updated 2 times
Summary
This study tested an experimental drug called zilebesiran in 36 Japanese adults with mild to moderate high blood pressure. The goal was to check its safety and how well it lowers blood pressure compared to a placebo. Participants received either the drug or a dummy shot, and their blood pressure and side effects were monitored for several months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD TO MODERATE HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Trial Site
Fukuoka, Japan
-
Clinical Trial Site
Osaka, Japan
-
Clinical Trial Site
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.